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Here, we review shortly the current knowledge on the regulation of the proteasomal system during and after
oxidative stress. After addressing the components of the proteasomal system and the degradation of oxidatively
damaged proteins in part I and II of this series, we address here which changes in activity undergo the
proteasome and the ubiquitin-proteasomal system itself under oxidative conditions. While several components
of the proteasomal system undergo direct oxidative modiﬁcation, a number of redox-regulated events are
modulating the proteasomal activity in a way it can address the major tasks in an oxidative stress situation: the
removal of oxidized proteins and the adaptation of the cellular metabolism to the stress situation.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Introduction
The main task of the ubiquitin-proteasomal-system (UPS) is the
maintenance of a functional proteome of the cell. The UPS consist of
two major pathways, the ATP-dependent 26S proteasome, degrading
polyubiquitinated substrates formed by the polyubiquitinating enzy-
matic machinery and the ATP-independent 20S proteasome-catalyzed
degradation pathway [1,2]. While interestingly, the 26S proteasomal
pathway is responsible for the degradation of a vast majority of
regulator proteins, the 20S proteasome is responsible for the degrada-
tion of oxidized proteins [3]. Therefore, during oxidative stress the
proteasomal system has to be adapted to the stress situation ensuring
a cellular regulatory response and the degradation of oxidized
proteins, as oxidative stress is not only involving cellular damage,
but also redox-regulation [4,5]. This damage and regulation is reﬂected
also in proteasomal modiﬁcations (Fig. 1). One of the more prominent
modiﬁcations is the glutathionylation of the proteasome. During
oxidative stress, the cellular redox-state shifts and the ratio of cellular
reduced and oxidized glutathione shifts leading to a modiﬁcation of
several proteasomal subunits. In addition to that several direct
oxidative modiﬁcations of the proteasome are taking place, including
protein oxidation leading to proteasome carbonylation, proteasomal
glycoxidation and modiﬁcation with lipid peroxidation products
(Fig. 1). It is assumed, that these modiﬁcations modulate the
proteasomal activity. However, to which extent these modiﬁcations
impair the proteasomal activity remains unknown today. Several
reports demonstrated that only high levels of damage to the 20S
proteasome lead to a catalytic impairment [6,7], whereas the 26S
proteasome is more susceptible towards oxidative damage [7,8].
Due to the requirement of an enhanced turnover of regulatory
proteins in a stress situation and the necessity to degrade oxidized
proteins, several components of the UPS are under the control of
stress-related transcription factors. One of those is the Nrf2-Keap1-
system [9]. So, oxidative stress is also able to induce de novo synthesis
of proteasomal subunits and parts of the UPS (Fig. 2). Interestingly, the
parts of the UPS are not only target genes of Nrf2, but the UPS itself
is also involved in the degradation of Keap1. The Keap1-Cul3-Rbx-
complex is catalyzing the polyubiqutination of Nrf2, making it a
substrate for the 26S proteasome. During oxidative stress, Keap1
becomes oxidized and is unable to catalyze the polyubiquitination of
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Nrf2. This is an example for the redox sensitivity of the ubiquitination
system, which was described earlier [10,11]. Although a wide array of
proteasomal subunits is regulated via Nrf2, for several proteasomal
components other transcription factors are involved. Especially the
inducible proteasomal subunits and the 11S proteasomal activator
(also Pa28) [1,2] are under the control of the Jak/Stat pathway (Fig. 3).
It was thought traditionally, that this pathway is only induced by the
cytokine interferon-γ (IFN-γ), but more recently also stress related
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factors – as glycoxidized proteins – are able to trigger this response,
although via a different receptor. Therefore, in late phases after
oxidative stress often an adaptive increase of proteasomal activity
was observed.
However, in several situations also a quick activation of the
proteasomal system seems to be needed. Especially in the nucleus
a quick and effective degradation of damaged proteins is required,
since such damaged proteins are likely to disturb DNA repair and
transcription related stress responses. Interestingly a link between
DNA repair and proteasomal activity was discovered, mediated by
the poly-ADP-ribosyl transferase 1 (PARP1) [12]. Formation of poly-
ADP-ribose is leading within minutes to a severalfold activation of
the proteasomal activity (Fig. 4). This is enabling the cell to degrade
rapidly damaged nuclear proteins and coordinate chromatin-refo-
rmation after stress events. Consequently, blocking of proteasomal
activity and/or inhibition of PARP was leading to inhibition or slow
down of DNA repair processes [13].
Summary
The proteasomal system undergoes in the event of oxidative
stress a series of regulators steps which are aiming to enable the
proteasomal system in the early phases after stress to remove
oxidized proteins, e.g. by activation of 20S proteasome by PARP1
and the inactivation of the 26S proteasome and the ubiqutination
enzymes, and in later phases the reformation of the 26S prote-
some and UPS to address regulatory requirements in the cell
accompanied by an activation of the 20S proteasome by PA28
(Fig. 5). The latter enables the proteasomal system further to cope
with remaining damaged proteins. This is followed by adaptive
responses enabling cell to cope with other oxidative stimuli by
synthesizing higher levels of proteosomes.
The left part of this ﬁgure shows a partial three-dimensional
reconstruction of the 26S proteasome build of the 19S regulator
protein (containing the 6 ATPases Rpt1–Rpt6 and the non-ATPase
subunits Rpn2, Rpn3 and Rpn5–Rpn13), the attaching alpha-ring
(subunits α1–α7) and one of the beta-rings (subunits β1–β7) of the
20S proteasome. This structure was described in detail in the ﬁrst
part of this series [1] and is here rendered according to the data
published by Sledz et al. [14], gained via cryoelectron microscopy
single-particle analysis.
Many of the 20S/26S proteasomal subunits have been shown
to be modiﬁed in different reactions, forming the according
adducts or speciﬁc modiﬁcations, as HNE-induced adducts
(HNE), protein carbonyls (PC), products of S-glutathionylation
(S-Glut.) or glycoxidation (Glyc.) as shown in the table on the
right. Certainly more subunits of both 20S and 19S can be
modiﬁed by ROS resulting in the induction of protein carbonyls,
but until now, the according products have not been shown
experimentally. The inhibitory effects of HNE-modiﬁcation on the
proteasome have already been described in detail [6,15–19].
Almost, every single alpha- and beta-subunits can be modiﬁed
by HNE, as well as Rpt4 of the 19S regulator. Formation of HNE-
adducts in proteins is often not a reversible modiﬁcation and it
can be assumed that massive HNE-adduct formation will prob-
ably decrease proteasomal activity. Besides of HNE-modiﬁcation,
many ROS are able to induce the formation of protein carbonyls,
the most common product of protein oxidation, in different
proteasomal subunits. The 19S-subunit Rpt3 (ATPase-subunit)
was shown by Ishii to be very susceptible to oxidation, in this
case induction of protein carbonyls via a copper-catalyzed
Fenton-system [20]. The formation of protein carbonyls is not a
reversible modiﬁcation, so the 26S-mediated degradation of
proteins is signiﬁcantly decreased [20] as was also shown
in other stress models [7]. A very important reversible
posttranslational modiﬁcation of proteasomal subunits is the
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Fig. 3. Jak/STAT-mediated induction of the inducible proteasome and PA28α/β.
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S-glutathionylation of certain cysteine-residues, found in both
the 20S proteasome and the 19S regulator. S-Glutathionylation is
the addition of glutathione to a cysteine-residue that can be
reversed in an enzymatic way. S-glutathionylation of 20S protea-
somal subunits affects mainly alpha subunits as shown predomi-
nantly in yeast, directly inﬂuencing their gating function and thus
proteasomal activity. The residues Cys76 and Cys221 of the α5-
subunit of the 20S in yeast were shown to be S-glutathionylated
in an ROS-dependent manner, increasing the proteasomal activity
via opening of the annulus [21]. The same modiﬁcation was found in
subunits of the 19S regulator: after H2O2-mediated S-glutathionyla-
tion of the 26S proteasome, 26S proteasomal activity decreased
signiﬁcantly, while 20S activity remained unchanged [22], as found
in isolated samples, as well as in HEK 293-cells and neutrophils.
The affected 19S subunits were Rpn1 and Rpn2, which play both a
role in recognition and binding of polyubiquitinated 26S-substrates
as well as in the transfer of those substrates to the 20S core for
terminal degradation [23]. Interestingly, also other components of
the UPS have been shown to be S-glutathionylated, so some E1 and
E2 enzymes, responsible for polyubiquitination of 26S proteasomal
substrates. All these enzymes contain a functional sulfhydryl, than
can be S-glutathionylated under oxidative stress, decreasing the
polybiquitinylation of native proteins [10,24]. Another predominant
modiﬁcation is glycoxidation of proteasomal subunits. This was
found for the ﬁrst time in the subunits α1–α3, as well as in β4–β6
of murine cardiac proteasomes [25]. Other studies found glycoxida-
tion of the subunits β2, β4 and β5 after incubation of proteasomes
with methyglyoxal (MGO), while no modiﬁcations in the alpha-
subunits were detected [26]. The same study revealed a signiﬁcantly
decreased chymotrypsin-like activity (β5-subunit) in the endothelial
cells after incubation with high glucose, as well as a reduction of the
19S regulator complex; in diabetic mice the proteasomal activity was
shown to be decreased, without any change in the proteasomal
protein levels detected [26].
Under normal conditions (no oxidative stress), the transcription
factor Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is kept in
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complex and thus inactive by the kelch-like ECH-associated protein 1
(Keap1) [9]. Keap1 forms a complex with Cul3 and Rbx1, which
function as an E3-ligase and mediates the polyubiquitination of Nrf2,
thus, labeling it as a substrate for 26S proteasomal degradation.
Consequently, the intracellular half-life of Nrf2 is very short (less than
30min [27]). In phases of oxidative stress, Keap1 may become
(oxidatively) damaged and Nrf2 is released into the cytosol. The
cysteine residues of Keap1 Cys151/273/288 [28] function as “redox-
sensors” inducing a shift in the tertiary structure of Keap1 after
oxidation that results in a release of Nrf2 from Keap1. The same effect
can be produced by Nrf2-inducers (like lipoic acid, curcumine or
sulforaphane [28]), that trigger the release of Nrf2 from Keap1 as well
as by proteasomal inhibition, preventing Nrf2 from proteolytic degra-
dation. After being released into the cytosol, Nrf2 becomes quickly
phosphorylated by phosphatidylinositol-3-kinase (PI3K) or protein
kinase B (PKB, also termed as Akt) and is then transported into the
cellular nucleus via the importins α5 and β1 [29]. Once in the nucleus,
it induces in combination with other transcription factors (sMaf, ATF4,
JunD and PMF-1 [30]) the expression of genes harboring the ARE/
EpRE-element. Thus, Nrf2 is one of the major factors in the antiox-
idative response of mammalian cells. This response can be suppressed
via Nrf2-siRNA or Nrf2-inhibitors, as retinoic acid [32]. That antiox-
idative response includes the expression of different enzymes
like NAD(P)H quinone oxidoreductase 1 (Nqo1), heme oxigenase-1
(HO-1), catalase (Cat), Cu/Zn-superoxide dismutase (SOD), glutathione
S-transferase (GST), multidrug resistance-associated proteins (Mrps),
UDP-glucuronosyltransferases (UGTs), glutamate-cysteine ligase
(GCLC, the rate- limiting enzyme in the synthesis of the antioxidant
glutathione), the cysteine/glutamate antiporter (xCT) and Nrf2 itself
[28,31]. Overall, these enzymes increase the cellular resistance to
oxidative and chemical stress. In addition to those also several
subunits of the proteasomal system are induced. A study using
microarrays identiﬁed the following subunits induced: α1 and α2, as
well as α3–α7 and β1–β6 of the 20S proteasome, together with the
19S-subunits Rpt1/2/5, Rpn2/5/6/8/9/10/11/12 and S5b, while both
subunits of Pa28 (also termed as 11S proteasome regulator) and the
inducible subunits of the proteasome were not detected [31]. Another
source mentions the alpha-subunits 1 and 2, the beta-subunits 3,
5 and 6, the 19S-subunits Rpt2, Rpt5, and Rpn11 all increase, as well as
no Pa28 or inducible 20S-subunits [28]. However, Pickering et al.
instead lists up 20S proteasomal subunits, as well as Pa28α and Pa28β
[32]. So the role of Nrf2 in the induction of Pa28 remains to be tested.
As already mentioned in part I of this series [1,2] several 20S
proteasomal subunits are inducible. The traditional inducers were
cytokines as γ-interferon [2]. However, as shown by Grimm et al.
[33], both interferon-gamma (IFN-γ) and advanced glycation end
products (AGEs) are able to induce the formation of both inducible
proteasomal subunits (β1i/2i/5i) and α- and β-subunits of the
proteasomal regulator protein Pa28 (also named 11S regulator).
IFN-γ is a cytokine involved in the activation of macrophages in
adaptive immune-response and is a recognized agent for the
induction of both the inducible proteasome and Pa28-subunits
[34], hence the name immunoproteasome. AGEs are glycoxidized
proteins that result from the non-enzymatic reaction of lysine
residues with different carbonyls. The common link between IFN-γ
and AGEs is the Janus kinase (Jak2) that can be induced by both
IFN-γ and AGEs. Binding of IFN-γ to the according receptor
(IFNGR1þ2, left part of the ﬁgure), induces phosphorylation and
release of Jak1 and Jak2 (blue) from the membrane-bound recep-
tor-complex into the cytosol. AGEs bind to the receptor for
advanced glycation end products (RAGE) that belongs to the
superfamily of immunoglobulins (right part of this ﬁgure), that is
formed of three immunoglobulin-like domains (two constant and
one variable type). The variable type is the critical one for the
recognition of AGEs [35]. The RAGE-mediated activation of Jak2
was shown to be inhibited with RAGE-siRNA, as well as both the
AGE and the IFN-γ mediated formation of immunoproteasomal
and Pa28-subunits via AG-490 or STAS-1-siRNA [33]. Jak2 activates
STAT1 (red) via a phosphorylation of its Tyr701 residue. After AGE-
treatment the amount of cellular phosphorylated STAT1 showed a
signiﬁcant increase [33]. Phosphorylated STAT1 forms homodi-
mers and is transported with the interferon regulatory factor-1
(IRF-1, yellow) into the nucleus. This cascade can be inhibited
effectively with STAT1 siRNA, too. After transport into the nucleus,
a complex of two phosphorylated STAT-1 proteins and interferon
regulatory factor-1 (IRF-1) bind to the interferon gamma activated
site (GAS), a short stretch of DNA, that functions as the promotor of
IFN-gamma-activated genes, in this case the interferon-stimulated
response element (ISRE) [36], that expresses (amongst others) the
inducible proteasomal subunits (β1i, β2i and β5i), that are incor-
porated into de novo synthesized 20S proteasomes, and the Pa28α-
and Pa28β-subunits of the 11S regulator.
Exposure of cells to highly reactive oxidants from different
sources (in this ﬁgure summarized as “ROS”), can damage various
cellular structures as proteins, lipids or RNA/DNA. Even if the bulk
of oxidative modiﬁcation is found in the cytosolic protein pool
[37–40], the nuclear DNA is not completely spared. Since the
proteins are subject to a constant turnover, moderate oxidative
modiﬁcation of proteins is not an acute threat for cellular viability
or functionality. In contrast, even slight oxidative damage to a
virtual static structure as the DNA, that is construed for perdur-
ability and not subjected to constant turnover, is very well
compromising cellular viability or functionality. Considering the
life span of the DNA in mammalian cells (and thus in whole
organisms), powerful systems are needed, that are able to recog-
nize and repair any DNA-damage immediately. One of the ﬁrst
“detectors” of oxidative DNA-damage like single-(SSB) and double-
strand breaks (DSB) is the nuclear poly(ADP-ribose)-polymerase-1
(PARP-1). Besides of PARP-1; PARP-2 and PARP-3 fulﬁll similar
tasks in recognition of DNA-damage and induction of repair-
cascades, but PARP-1 is the most active one of this group [41].
After binding to SSB/DSB, PARP-1 is actively producing poly-ADP-
ribose. PARP-1s main targets of poly(ADP-ribosyl)ation are his-
tones. Further targets are NF-κB, p53, DNA-topoisomerases, DNA-
PKcs, PARP-1 itself [42] and the nuclear 20S proteasome [13,43,44].
Interestingly, the poly(ADP-ribosyl)ation of histones seems to be
restricted to the non-damaged ones, while oxidatively damaged
histones are not modiﬁed by PARP-1. Therefore, PARP-1-mediated
modiﬁcation of histones seems to have a protective, selection-like
effect preserving functional histones from proteasomal degrada-
tion [13]. While PARP-1 modiﬁes its targets, large amounts of
NADþ are consumed. In the presence of DNA-damage, the PARP-1
activity can increase very quickly, and thus, the limiting substrate
of mitochondrial ATP-synthesis (NADþ) is depleted. Recently
PARP-1 is considered as the link between the DNA damage repair
machinery and the remove of oxidatively damaged nuclear pro-
teins [13]. Poly(ADP-ribosyl)ation of PARP-1-targets can be pre-
vented effectively with speciﬁc inhibitors like 2-ABA or PJ-34 [13],
while the PARP-1-mediated proteasomal activation can be sup-
pressed effectively with both proteasomal inhibitors like lactacys-
tin (LC) and PARP-1 inhibitors [13,44]. As mentioned in the ﬁrst
part of this series [1,2], the proteasomal activity declines in aged
cells, even if there is no change in the amount of proteasome that
may be due to proteasomal inhibition via protein aggregates [45–
49]. The decline of the nuclear proteasomal fraction turned out to
be less distinct, even if the amount of protein oxidation in the
nucleus is higher in aged than in young cells, though no large
covalently cross-linked protein aggregates are found there [37,40].
Experiments to clarify those questions revealed that the nuclear
proteasomal PARP-1-mediated activation in senescent mammalian
cells seems to be decreased due to a decrease in the amount of
PARP-1 [44]. This PARP-1-mediated proteasomal activation has
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been shown in different cell types [12,50–53], plays an essential
role in the recognition and removal of oxidized histones and thus
contributes to restore of DNA integrity. Furthermore, decreased
PARP-1-function results in an increased DNA-damage as well as
lowered amount of proteolytic degradation of damaged histones.
Consequently, repair of hydrogen peroxide induced DNA-damage
(quantiﬁed via 8-OHdG formation) was effectively abolished via
proteasomal inhibitors, as well as by inhibition of PARP-1 [13].
One of the ﬁrst stress-responses of the UPS is the proteasomal
activation by nuclear PARP-1 as described in detail above (see Fig. 4).
Furthermore, a rapid decline of the 26S proteasomal activity takes
place, which is driven by an Hsp70-mediated detachment of the 19S
regulator from the 26S proteasome [54]. In the cytosol, additional
stress-induced modiﬁcations like S-glutathionylation and phosphor-
ylation may play additional roles in the activation of free 20S “core”
proteasome as well as in inactivation/disassembly of the 26S protea-
some. All this takes place in a time frame of minutes (5–30 min,
depending on the cell type). By liberation of the 20S proteasome
from the 26S proteasomal particle an enhanced binding of the Pa28
proteasome activator takes place, leading to an effective breakdown
of oxidized proteins [3]. This degradation of oxidized proteins is
completed between 3 and 24 h after the stress. After coping with the
most dramatic redox-related cellular changes within a few hours the
26S proteasome re-assembles again releasing Hsp70 and the
ubiquitin-proteasomal-system (UPS) is reactivated [54]. In later hours
after the stress exposure (some 12–72 h) a de novo synthesis of
proteasome, inducible proteasome and Pa28- and Pa700-subunits is
induced, signiﬁcantly increasing the proteolytic capacity of the cell.
Consequently, low amounts of oxidative stress (like “pretreatment”
with low amounts of oxidants) can induce an increased resistance of
the cell to following events of oxidative stress [55], an effect termed
as ‘adaptation’ or ‘hormesis’.
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